BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 32528898)

  • 1. Patient Derived Xenografts Expand Human Primary Pancreatic Tumor Tissue Availability for
    Brock RM; Beitel-White N; Coutermarsh-Ott S; Grider DJ; Lorenzo MF; Ringel-Scaia VM; Manuchehrabadi N; Martin RCG; Davalos RV; Allen IC
    Front Oncol; 2020; 10():843. PubMed ID: 32528898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irreversible electroporation ablation overcomes tumor-associated immunosuppression to improve the efficacy of DC vaccination in a mice model of pancreatic cancer.
    Yang J; Eresen A; Shangguan J; Ma Q; Yaghmai V; Zhang Z
    Oncoimmunology; 2021 Feb; 10(1):1875638. PubMed ID: 33643692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irreversible electroporation promotes a pro-inflammatory tumor microenvironment and anti-tumor immunity in a mouse pancreatic cancer model.
    Imran KM; Brock RM; Beitel-White N; Powar M; Orr K; Aycock KN; Alinezhadbalalami N; Salameh ZS; Eversole P; Tintera B; Markov Madanick J; Hendricks-Wenger A; Coutermarsh-Ott S; Davalos RV; Allen IC
    Front Immunol; 2024; 15():1352821. PubMed ID: 38711517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of pancreatic cancer with irreversible electroporation and intratumoral CD40 antibody stimulates systemic immune responses that inhibit liver metastasis in an orthotopic model.
    Shankara Narayanan JS; Hayashi T; Erdem S; McArdle S; Tiriac H; Ray P; Pu M; Mikulski Z; Miller A; Messer K; Carson D; Schoenberger S; White RR
    J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36634919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irreversible electroporation therapy in the management of locally advanced pancreatic adenocarcinoma.
    Martin RC; McFarland K; Ellis S; Velanovich V
    J Am Coll Surg; 2012 Sep; 215(3):361-9. PubMed ID: 22726894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of Irreversible Electroporation Ablation as Adjunctive Treatment for Margin Enhancement: Safety and Efficacy.
    Simmerman E; Chung J; Lawson A; Kruse E
    J Surg Res; 2020 Feb; 246():260-268. PubMed ID: 31610354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irreversible Electroporation Enhanced by Radiofrequency Ablation: An In Vitro and Computational Study in a 3D Liver Tumor Model.
    Fang Z; Mao H; Moser MAJ; Zhang W; Qian Z; Zhang B
    Ann Biomed Eng; 2021 Sep; 49(9):2126-2138. PubMed ID: 33594637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell activation and immune memory enhancement induced by irreversible electroporation in pancreatic cancer.
    He C; Huang X; Zhang Y; Lin X; Li S
    Clin Transl Med; 2020 Jun; 10(2):e39. PubMed ID: 32508058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controllable Moderate Heating Enhances the Therapeutic Efficacy of Irreversible Electroporation for Pancreatic Cancer.
    Edelblute CM; Hornef J; Burcus NI; Norman T; Beebe SJ; Schoenbach K; Heller R; Jiang C; Guo S
    Sci Rep; 2017 Sep; 7(1):11767. PubMed ID: 28924200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of irreversible electroporation in human pancreatic adenocarcinoma: advanced murine model.
    Philips P; Li Y; Li S; St Hill CR; Martin RC
    Mol Ther Methods Clin Dev; 2015; 2():15001. PubMed ID: 26029712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Irreversible electroporation augments β-glucan induced trained innate immunity for the treatment of pancreatic ductal adenocarcinoma.
    Woeste MR; Shrestha R; Geller AE; Li S; Montoya-Durango D; Ding C; Hu X; Li H; Puckett A; Mitchell RA; Hayat T; Tan M; Li Y; McMasters KM; Martin RCG; Yan J
    J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37072351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irreversible Electroporation: An Emerging Immunomodulatory Therapy on Solid Tumors.
    Zhang N; Li Z; Han X; Zhu Z; Li Z; Zhao Y; Liu Z; Lv Y
    Front Immunol; 2021; 12():811726. PubMed ID: 35069599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial Assessment of the Efficacy of Irreversible Electroporation in the Focal Treatment of Localized Renal Cell Carcinoma With Delayed-interval Kidney Tumor Resection (Irreversible Electroporation of Kidney Tumors Before Partial Nephrectomy [IRENE] Trial-An Ablate-and-Resect Pilot Study).
    Wendler JJ; Pech M; Fischbach F; Jürgens J; Friebe B; Baumunk D; Porsch M; Blaschke S; Schindele D; Siedentopf S; Ricke J; Schostak M; Köllermann J; Liehr UB
    Urology; 2018 Apr; 114():224-232. PubMed ID: 29305201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor Ablation Enhancement by Combining Radiofrequency Ablation and Irreversible Electroporation: An In Vitro 3D Tumor Study.
    Zhang B; Yang Y; Ding L; Moser MAJ; Zhang EM; Zhang W
    Ann Biomed Eng; 2019 Mar; 47(3):694-705. PubMed ID: 30565007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of IRE in multi-modality treatment for oligometastatic pancreatic cancer.
    Hong Y; Rice J; Sharma D; Martin RCG
    Am J Surg; 2018 Jul; 216(1):106-110. PubMed ID: 29506753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer cells ablation with irreversible electroporation.
    Miller L; Leor J; Rubinsky B
    Technol Cancer Res Treat; 2005 Dec; 4(6):699-705. PubMed ID: 16292891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of irreversible electroporation (IRE) for locally advanced pancreatic cancer: a systematic review of safety and efficacy.
    Ansari D; Kristoffersson S; Andersson R; Bergenfeldt M
    Scand J Gastroenterol; 2017 Nov; 52(11):1165-1171. PubMed ID: 28687047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications and considerations of thermal effects when applying irreversible electroporation tissue ablation therapy.
    Davalos RV; Bhonsle S; Neal RE
    Prostate; 2015 Jul; 75(10):1114-8. PubMed ID: 25809014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo characterization and numerical simulation of prostate properties for non-thermal irreversible electroporation ablation.
    Neal RE; Millar JL; Kavnoudias H; Royce P; Rosenfeldt F; Pham A; Smith R; Davalos RV; Thomson KR
    Prostate; 2014 May; 74(5):458-68. PubMed ID: 24442790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Research Progress of Catheter-based Irreversible Electroporation for Tissue Ablation].
    Zhou Y; Han X; Ren F; Li Q; Chen X; Chu D; Wu R; Lyu Y
    Zhongguo Yi Liao Qi Xie Za Zhi; 2020 Feb; 44(2):172-178. PubMed ID: 32400994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.